Assessing the intracellular concentration of platinum in medulloblastoma cell lines after Cisplatin incubation

Journal of Trace Elements in Medicine and Biology

Volumn 28, Issue 2, 2014, Pages 166-172

  Wehe, Christoph A ^a   Beyer, Georg ^b   Sperling, Michael ^a   Ciarimboli, Giuliano ^b   Karst, Uwe ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Cisplatin; Cytostatics; Flow injection; ICP MS; Intracellular quantitation

Indexed keywords

CISPLATIN; PLATINUM; OCTAMER TRANSCRIPTION FACTOR 2;

ARTICLE; CALIBRATION; CELL LEVEL; CELL VIABILITY; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOLYSIS; CYTOSTASIS; CYTOTOXICITY; FLOW INJECTION ANALYSIS; FLOW RATE; HUMAN; HUMAN CELL; LIMIT OF DETECTION; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; MEASUREMENT PRECISION; PRESCHOOL CHILD; PRIORITY JOURNAL; REPRODUCIBILITY; TUMOR CELL LINE; CELL DEATH; CYTOTOXICITY TEST; ISOTOPE DILUTION ASSAY; MEASUREMENT ACCURACY; MEDULLOBLASTOMA CELL LINE; PROTEIN CONTENT; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; ATOMIC ABSORPTION SPECTROMETRY; DRUG EFFECTS; INTRACELLULAR SPACE; MEDULLOBLASTOMA; METABOLISM; PATHOLOGY; PROCEDURES;

CALIBRATION; CELL LINE, TUMOR; CISPLATIN; FLOW INJECTION ANALYSIS; HUMANS; INTRACELLULAR SPACE; MEDULLOBLASTOMA; PLATINUM; SPECTROPHOTOMETRY, ATOMIC;

EID: 84898036178     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.01.001     Document Type: Article

References (49)

1. Rosenberg B., Van Camp L., Krigas T. Inhibition of cell division in Escherichia Coli by electrolysis products from a platinum electrode. Nature 1965, 205:698-699.
2. Rosenberg B., Van Camp L., Grimley E.B., Thomson A.J. The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum(IV) complexes. J Biol Chem 1967, 242:1347-1352.
3. Rosenberg B., Van Camp L., Trosko J.E., Mansour V.H. Platinum compounds: a new class of potent antitumouragents. Nature 1969, 222:385-386.
4. Ciarimboli G. Role of organic cation transporters in drug-induced toxicity. Expert Opin Drug Met 2011, 7:159-174.
5. Ciarimboli G., Deuster D., Knief A., Sperling M., Holtkamp M., Edemir B., et al. Organic cation transporter 2 mediates Cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol 2010, 176:1169-1180.
6. Björn E., Nygren Y., Nguyen T.T.T.N., Ericson C., Nöjd M., Naredi P. Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry. Anal Biochem 2007, 363:135-142.
7. Reifschneider O., Wehe C.A., Raj I., Ehmcke J., Ciarimboli G., Sperling M., et al. Quantitative bioimaging of platinum in polymer embedded mouse organs using laser ablation ICP-MS analysis. Metallomics 2013, 5:1440-1447.
8. Rabik C.A., Dolan M.E. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007, 33:9-23.
9. Ciarimboli G., Ludwig T., Lang D.F., Pavenstädt H., Koepsell H., Piechota H.J., et al. Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter. Am J Pathol 2005, 167:1477-1484.
10. Brauckmann C., Wehe C.A., Kieshauer M., Lanvers-Kaminsky C., Sperling M., Karst U. The interaction of platinum-based drugs with native biologically relevant proteins. Anal Bioanal Chem 2013, 405:1855-1864.
11. Miller R.P., Tadagavadi R.K., Ramesh G., Reeves W.B. Mechanisms of Cisplatin nephrotoxicity. Toxins 2010, 2:2490-2518.
12. Galanski M., Arion V.B., Jakupec M.A., Keppler B.K. Recent developments in the field of tumor-inhibiting metal complexes. Curr Pharm Des 2003, 9:2078-2089.
13. Ding D.L., Allman B.L., Salvi R. Review: ototoxic characteristics of platinum antitumor drugs. Anat Rec 2012, 295:1851-1867.
14. Siddik Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003, 22:7265-7279.
15. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007, 7:573-584.
16. Topkan E., Parlak C., Topuk S., Guler O.C., Selek U. Outcomes of aggressive concurrent radiochemotherapy in highly selected septuagenararians with Stage IIIB non-small-cell lung carcinoma: retrospective analysis of 89 patients. Lung Cancer 2013, 81:226-230.
17. Gauler T.C., Christoph D.C., Fischer J., Frickhofen N., Huber R., Gonschorek C., et al. Phase-I study of sagopilone in combination with cisplatin in chemotherapy-naive patients with metastasised small-cell lung cancer. Eur J Cancer 2013, 49:2461-2468.
18. Beyer J., Albers P., Altena R., Aparicio J., Bokemeyer C., Busch J., et al. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the Third European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer. Ann Oncol 2013, 24:878-888.
19. Glendenning J.L., Barbachano Y., Norman A.R., Dearnaley D.P., Horwich A., Huddart R.A. Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer. Cancer 2010, 116:2322-2331.
20. Packer R.J., Gajjar A., Vezina G., Rorke-Adams L., Burger P.C., Robertson P.L., et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006, 24:4202-4208.
21. Lannering B., Rutkowski S., Doz F., Pizer B., Gustafsson G., Navajas A., et al. Hyperfractionatedversus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol 2012, 30:3187-3193.
22. Růžička J., Hansen E.H. Flow injection analyses: part I. A new concept of fast continuous flow analysis. Anal Chim Acta 1975, 78:145-157.
23. Welz B., Sperling M. Flow injection: the ultimate approach to automation in analytical atomic spectroscopy. Pure Appl Chem 1993, 65:2465-2472.
24. Heithmar E.M., Hinners T.A., Rowan J.T., Riviello J.M. Minimization of interferences in inductively coupled plasma mass spectrometry using on-line preconcentration. Anal Chem 1990, 62:857-864.
25. Viczián M., Lásztity A., Wang X., Barnes R.M. On-line isotope dilution and sample dilution by flow injection and inductively coupled plasma mass spectrometry. J Anal At Spectrom 1990, 5:125-133.
26. Wehe C.A., Bornhorst J., Holtkamp M., Sperling M., Galla H.J., Schwerdtle T., et al. Fast and low sample consuming quantification of manganese in cell nutrient solutions by flow injection ICP-QMS. Metallomics 2011, 3:1291-1296.
27. Greenfield S. Inductively coupled plasma-atomic emission spectroscopy (ICP-AES) with flow injection analysis (FIA). Spectrochim Acta B 1983, 38:93-105.
28. Gallego M., Luque de Castro M.D., Valcárcel M. Atomic spectroscopic techniques in flow injection analysis: a review. At Spectrosc 1985, 6:16-22.
29. Dean J.R., Ebdon L., Crews H.M., Massey R.C. Characteristics of flow injection inductively coupled plasma mass spectrometry for trace metal analysis. J Anal At Spectrom 1988, 3:349-354.
30. Stroh A., Völlkopf U., Denoyer E.R. Analysis of samples containing large amounts of dissolved solids using microsampling flow injection inductively coupled plasma mass spectrometry. J Anal At Spectrom 1992, 7:1201-1205.
31. Nelms S.M., Quétel C.R., Prohaska T., Vogl J., Taylor P.D.P. Evaluation of detector dead time calculation models for ICP-MS.y. J Anal At Spectrom 2001, 16:333-338.
32. Jacobsen P.F., Jenkyn D.J., Papadimitriou J.M. Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 1985, 44:472-485.
33. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
34. Tada H., Shiho O., Kuroshima K., Koyama M., Tsukamoto K. An improved colorimetric assay for interleukin 2. J Immunol Methods 1986, 93:157-165.
35. Lanvers-Kaminsky C., Bremer A., Dirksen U., Jürgens H., Boos J. Cytotoxicity of treosulfan and busulfan on pediatrictumor cell lines. Anticancer Drugs 2006, 17:657-662.
36. Berridge M.V., Tan A.S., McCoy K.D., Wang R. The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts. Biochemica 1996, 4:14-19.
37. Berridge M.V., Herst P.M., Tan A.S. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 2005, 11:127-152.
38. Berridge M.V., Tan A.S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993, 303:474-482.
39. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
40. Fassett J.D., Paulsen P.J. Isotope dilution mass spectrometry for accurate elemental analysis. Anal Chem 1989, 61:643A-649A.
41. Heumann K.G., Gallus S.M., Rädlinger G., Vogl J. Precision and accuracy in isotope ratio measurements by plasma source mass spectrometry. J Anal At Spectrom 1998, 13:1001-1008.
42. Heumann K.G. Isotope-dilution ICP-MS for trace elementdetermination and speciation: from a reference method to a routine method?. Anal Bioanal Chem 2004, 378:318-329.
43. Rodríguez-González P., Marchante-Gayón J.M., García-Alonso J.I., Sanz-Medel A. Isotope dilution analysis for elemental speciation: a tutorial review. Spectrochim Acta B 2005, 60:151-207.
44. Vanhaecke F., Vanhoe H., Dams R., Vandecasteele C. The use of internal standards in ICP-MS. Talanta 1992, 39:737-742.
45. Tanner S.D., Baranov V.I., Bandura D.R. Reaction cells and collision cells for ICP-MS:a tutorial review. Spectrochim Acta B 2002, 57:1361-1452.
46. Boumans P.W.J.M. Measuring detection limits in inductively coupled plasma emission spectrometry using the "SBR-RSDB approach"-I. A tutorial discussion of the theory. Spectrochim Acta B 1991, 46:431-445.
47. Tran M.Q.T., Nygren Y., Lundin C., Naredi P., Björn E. Evaluation of cell lysis methods for platinum metallomic studies of human malignant cells. Anal Biochem 2010, 396:76-82.
48. Zhang S.Z., Lovejoy K.S., Shima J.E., Lagpacan L.L., Shu Y., Lapuk A., et al. Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Res 2006, 66:8847-8857.
49. Cepeda V., Fuertes M.A., Castilla J., Alonso C., Quevedo C., Pérez J.M. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 2007, 7:3-18.